Acute myeloid leukemia targets for bispecific antibodies
Crossref DOI link: https://doi.org/10.1038/bcj.2017.2
Published Online: 2017-02-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hoseini, S S
Cheung, N K
Text and Data Mining valid from 2017-02-03
Version of Record valid from 2017-02-03
Article History
Received: 18 November 2016
Accepted: 22 November 2016
First Online: 3 February 2017
Competing interests
: MSKCC and NK Cheung have financial interest in Y-mabs Therapeutics Inc.